奧里尼亞製藥公司
DE ˙ DB ˙ CA05156V1022
€13.91 ↑0.53 (3.96%)
2026-06-04
分享價格
SecurityDE:IKAP / Aurinia Pharmaceuticals Inc.
InstitutionVanguard Group Inc
Latest Disclosed Ownership1,449,884 shares
Latest Disclosed Value $ 23,125,650
Vanguard Group Inc reports 6.91% decrease in ownership of IKAP / Aurinia Pharmaceuticals Inc.

On January 29, 2026 - Vanguard Group Inc filed a 13F-HR form disclosing ownership of 1,449,884 shares of Aurinia Pharmaceuticals Inc. (DE:IKAP) valued at $19,189,215 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 7, 2025 disclosing 1,557,509 shares of Aurinia Pharmaceuticals Inc.. This represents a change in shares of -6.91% during the quarter. The current value of the position is $20,167,886 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-01-29 2025-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 1,449,884 -107,625 -6.91 23,126 34.37 0.0003
2025-11-07 2025-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 1,557,509 -163,369 -9.49 17,210 18.08 0.0003
2025-08-11 2025-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 1,720,878 -250,928 -12.73 14,576 -8.06 0.0002
2025-05-09 2025-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 1,971,806 241,858 13.98 15,853 2.05 0.0003
2025-02-11 2024-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 1,729,948 112,113 6.93 15,535 31.00 0.0003
2024-11-13 2024-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 1,617,835 78,723 5.11 11,859 34.93 0.0002
2024-08-13 2024-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 1,539,112 7,495 0.49 8,788 14.53 0.0002
2024-05-10 2024-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 1,531,617 21,119 1.40 7,673 -43.49 0.0002
2024-03-11 2023-12-31 13F/A-1 AURINIA PHARMACEUTICALS COM 05156V102 1,510,498 26,230 1.77 13,579 17.75 0.0003
2024-02-14 2023-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 1,509,161 24,893 13,567 0.0003
2023-12-18 2023-09-30 13F/A-1 AURINIA PHARMACEUTICALS COM 05156V102 1,484,268 101,751 7.36 11,533 -13.82 0.0003
2023-11-14 2023-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 1,484,268 101,751 11,533 0.0001
2023-08-14 2023-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 1,382,517 54,407 4.10 13,383 -8.07 0.0003
2023-07-14 2023-03-31 13F/A-1 AURINIA PHARMACEUTICALS COM 05156V102 1,328,110 -46,413 -3.38 14,556 145.17 0.0004
2023-05-15 2023-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 1,328,110 -46,413 14,556 0.0001
2023-02-10 2022-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 1,374,523 166,914 13.82 5,938 -34.62 0.0002
2022-11-14 2022-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 1,207,609 38,652 3.31 9,081 -22.71 0.0003
2022-08-12 2022-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 1,168,957 638,898 120.53 11,749 79.05 0.0003
2022-05-13 2022-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 530,059 110,354 26.29 6,562 -31.64 0.0002
2022-02-14 2021-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 419,705 347,094 478.02 9,599 497.32 0.0002
2021-11-12 2021-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 72,611 75 0.10 1,607 70.96 0.0000
2021-08-13 2021-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 72,536 -19,890 -21.52 940 -21.67 0.0000
2021-05-14 2021-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 92,426 -2,728 -2.87 1,200 -8.81 0.0000
2021-02-12 2020-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 95,154 15,226 19.05 1,316 11.71 0.0000
2020-11-16 2020-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 79,928 22,626 39.49 1,178 26.53 0.0000
2020-08-14 2020-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 57,302 -39,844 -41.01 931 -33.97 0.0000
2020-05-15 2020-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 97,146 49,197 102.60 1,410 45.21 0.0001
2020-02-14 2019-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 47,949 18,929 65.23 971 526.45 0.0000
2019-11-14 2019-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 29,020 0 0.00 155 -18.85 0.0000
2019-08-14 2019-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 29,020 4,549 18.59 191 20.13 0.0000
2019-05-15 2019-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 24,471 9,700 65.67 159 57.43 0.0000
2019-02-14 2018-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 14,771 0 0.00 101 3.06 0.0000
2018-12-13 2018-09-30 13F/A-2 AURINIA PHARMACEUTICALS COM 05156V102 14,771 0 0.00 98 18.07 0.0000
2018-11-23 2018-09-30 13F/A-1 AURINIA PHARMACEUTICALS COM 05156V102 14,771 0 98 0.0000
2018-11-14 2018-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 14,771 0 98
2018-08-14 2018-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 14,771 0 0.00 83 7.79 0.0000
2018-05-15 2018-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 14,771 0 0.00 77 14.93 0.0000
2018-02-14 2017-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 14,771 14,771 67 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.